Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...

The Prismaflex (Gambro, Lakewood, CO) integrated CRRT system was introduced to our hospital and used to provide renal replacement therapy for ECLS patients in April 2009. Prior to this time ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

The trial’s primary endpoint is a composite of 90-day mortality or dialysis dependency of patients treated with SCD in addition to CRRT as the standard of care, compared with the control group ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...

The trial is assessing the efficacy and safety of the company's selective cytopheretic device (SCD) in conjunction with continuous renal replacement therapy (CRRT). The trial aims to enrol 200 adult ...

Learn more about whether Baxter International Inc. or Smith & Nephew plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The renal-electrolyte division reached a consensus on the content of the preprinted order set, the restricted ordering process, and the concept and selection of the standardized CRRT solution ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces ...